Developer docs
API playgroundTry for free, no card

Search company profiles

Aenorasis

Full company profile

uuid000tkqq

Namestring
Aenorasis
Websiteurl
aenorasis.com
Company typeenum
Private
Founded yearint
1998
Descriptiontext

Aenorasis is a private, for-profit pharmaceutical distribution company headquartered in Athens, Greece, founded in 1998. Per its firmographic profile, the company specializes in the distribution of medical devices, therapeutic, and diagnostic products, positioning it as a multi-category healthcare wholesaler serving the Greek market. With 51-100 employees, Aenorasis sits in the small-to-mid-cap bracket of Greek pharma/medical distribution, an industry segment that requires GDP (Good Distribution Practice) licensing, cold-chain logistics capability for therapeutics and diagnostics, and compliance with EU medical device traceability regulations.

The company's business model is inferred to follow a classic pharmaceutical/medical device wholesaler structure: sourcing products from manufacturers or upstream wholesalers, holding regulated inventory, and distributing to downstream buyers such as hospitals, clinics, retail pharmacies, and diagnostic laboratories. Revenue mechanics in this segment are typically volume-based with thin gross margins, monetized through buy-sell spreads on therapeutic SKUs and service/handling fees on specialty devices and diagnostics. No pricing models, customer logos, contract structures, or channel partnerships are publicly disclosed, and the company website returned only a loading/verification placeholder, indicating limited public-facing commercial transparency.

No information on the management team, ownership structure, funding history, M&A activity, certifications, awards, partnerships, or product portfolio is available in the input data. The absence of disclosed financials, headcount trends, or strategic milestones means that Aenorasis's operational scale, recent performance, and competitive positioning cannot be triangulated beyond the firmographic snapshot. From an investment-analyst standpoint, the company presents as a long-tenured (25+ years) but data-opaque Greek healthcare distributor whose deeper diligence will require direct outreach to obtain financials, customer mix, and growth signals.

Short descriptiontext

Aenorasis is a private Greek pharmaceutical distributor, founded in 1998 and headquartered in Athens, that supplies medical devices, therapeutic, and diagnostic products to downstream healthcare buyers with a team of 51-100 employees.

Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersAthens, Greece
HQ citystring
Athens
HQ countrystring
Greece
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
pharmaceutical distribution, medical device distribution, therapeutic products, diagnostic products, healthcare supply
Industry1 code
PRIMARYHLAIAJAC
OTC & Consumer Health Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
NAICS code1 code
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
SIC code2 codes
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Pharmaceutical Distribution
Social media profiles1 record
Cost components4 values
Supply Chain, Operations, Personnel, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Aenorasis is a pharmaceutical distribution company based in Athens, Greece, founded in 1998. It specializes in distributing medical devices, therapeutic products, and diagnostic products to healthcare customers. The company operates with 51-100 employees and focuses on the supply of healthcare-related products.

Differentiator
Functional benefit
Problem solved
No data
Peers8 records
TypeDirect peer
Description

Greek pharmaceutical distribution company with similar therapeutic product portfolio. Directly comparable as a domestic Greek pharma distributor operating at overlapping customer segments (pharmacies, hospitals) with a parallel business model.

TypeRegional player
Description

Greek pharmaceutical company combining manufacturing and distribution of therapeutic products. Comparable as a Greek peer with overlapping product portfolio in therapeutic categories and similar domestic market exposure.

TypeRegional player
Description

Greek pharmaceutical manufacturer and distributor headquartered in Athens. Comparable as a Greece-based pharma player with overlapping therapeutic categories and shared customer base in the Greek market.

TypeRegional player
Description

Greek pharmaceutical company specializing in distribution of therapeutic products. Comparable as a domestic Greek peer with similar distribution business model and customer base.

5Alliance Healthcare (Walgreens Boots Alliance)
TypeBroad incumbent
Description

European pharmaceutical wholesale and distribution business within Walgreens Boots Alliance. Comparable as a large-scale pharma distributor with similar product categories and pharmacy customer base across Europe.

TypeBroad incumbent
Description

Pan-European pharmaceutical wholesale and distribution group. Comparable as a large-scale pharma distributor operating across therapeutic categories — represents both a competitor and a potential roll-up acquirer of Aenorasis.

7Celesio (McKesson Europe)
TypeBroad incumbent
Description

European pharmaceutical distribution and pharmacy operator owned by McKesson. Comparable as a major pharma wholesaler with similar B2B distribution model, serving pharmacies and hospitals across European markets including Greece.

TypeRegional player
Description

Greek pharmaceutical company with distribution operations across therapeutic and consumer health categories. Comparable as a Greek-headquartered player operating in pharmaceutical distribution with similar therapeutic product focus.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights3 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Aenorasis

Pharmaceutical Distributionaenorasis.com

Aenorasis is a private Greek pharmaceutical distributor, founded in 1998 and headquartered in Athens, that supplies medical devices, therapeutic, and diagnostic products to downstream healthcare buyers with a team of 51-100 employees.

What Aenorasis does

Aenorasis is a private, for-profit pharmaceutical distribution company headquartered in Athens, Greece, founded in 1998. Per its firmographic profile, the company specializes in the distribution of medical devices, therapeutic, and diagnostic products, positioning it as a multi-category healthcare wholesaler serving the Greek market. With 51-100 employees, Aenorasis sits in the small-to-mid-cap bracket of Greek pharma/medical distribution, an industry segment that requires GDP (Good Distribution Practice) licensing, cold-chain logistics capability for therapeutics and diagnostics, and compliance with EU medical device traceability regulations.

The company's business model is inferred to follow a classic pharmaceutical/medical device wholesaler structure: sourcing products from manufacturers or upstream wholesalers, holding regulated inventory, and distributing to downstream buyers such as hospitals, clinics, retail pharmacies, and diagnostic laboratories. Revenue mechanics in this segment are typically volume-based with thin gross margins, monetized through buy-sell spreads on therapeutic SKUs and service/handling fees on specialty devices and diagnostics. No pricing models, customer logos, contract structures, or channel partnerships are publicly disclosed, and the company website returned only a loading/verification placeholder, indicating limited public-facing commercial transparency.

No information on the management team, ownership structure, funding history, M&A activity, certifications, awards, partnerships, or product portfolio is available in the input data. The absence of disclosed financials, headcount trends, or strategic milestones means that Aenorasis's operational scale, recent performance, and competitive positioning cannot be triangulated beyond the firmographic snapshot. From an investment-analyst standpoint, the company presents as a long-tenured (25+ years) but data-opaque Greek healthcare distributor whose deeper diligence will require direct outreach to obtain financials, customer mix, and growth signals.

Aenorasis firmographics

Firmographics
Name
Aenorasis
Website
https://aenorasis.com
Company type
Private
Founded year
1998
Headcount range
1–10 employees
Short description
Aenorasis is a private Greek pharmaceutical distributor, founded in 1998 and headquartered in Athens, that supplies medical devices, therapeutic, and diagnostic products to downstream healthcare buyers with a team of 51-100 employees.
Ownership category
akta.pro rank

Aenorasis industry classification

Industry
Product category
Pharmaceutical Distribution
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (42421)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro industry
PRIMARYHLAIAJAC
OTC & Consumer Health Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling

Keywords

  • Pharmaceutical distribution
  • Medical device distribution
  • Therapeutic products
  • Diagnostic products
  • Healthcare supply

Where Aenorasis is headquartered

Location

Headquarters

HQ city
Athens
HQ country
Greece
HQ region
Europe

Markets served

Aenorasis business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales

Aenorasis product offering

Product offering

Core offering

Aenorasis is a pharmaceutical distribution company based in Athens, Greece, founded in 1998. It specializes in distributing medical devices, therapeutic products, and diagnostic products to healthcare customers. The company operates with 51-100 employees and focuses on the supply of healthcare-related products.

Differentiator

Problem solved

Functional benefit

Companies that use Aenorasis

Customer profile

Ideal customer profiles1 record

Aenorasis technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Aenorasis competitors and assessment

Company assessment

Direct peers

  • Help Pharmaceuticals: Greek pharmaceutical distribution company with similar therapeutic product portfolio. Directly comparable as a domestic Greek pharma distributor operating at overlapping customer segments (pharmacies, hospitals) with a parallel business model.

Regional players

  • Uni-Pharma: Greek pharmaceutical company combining manufacturing and distribution of therapeutic products. Comparable as a Greek peer with overlapping product portfolio in therapeutic categories and similar domestic market exposure.
  • Elpen Pharmaceutical: Greek pharmaceutical manufacturer and distributor headquartered in Athens. Comparable as a Greece-based pharma player with overlapping therapeutic categories and shared customer base in the Greek market.
  • Genepharm: Greek pharmaceutical company specializing in distribution of therapeutic products. Comparable as a domestic Greek peer with similar distribution business model and customer base.
  • Lavipharm: Greek pharmaceutical company with distribution operations across therapeutic and consumer health categories. Comparable as a Greek-headquartered player operating in pharmaceutical distribution with similar therapeutic product focus.

Broad incumbents

  • Alliance Healthcare (Walgreens Boots Alliance): European pharmaceutical wholesale and distribution business within Walgreens Boots Alliance. Comparable as a large-scale pharma distributor with similar product categories and pharmacy customer base across Europe.
  • Phoenix Group: Pan-European pharmaceutical wholesale and distribution group. Comparable as a large-scale pharma distributor operating across therapeutic categories — represents both a competitor and a potential roll-up acquirer of Aenorasis.
  • Celesio (McKesson Europe): European pharmaceutical distribution and pharmacy operator owned by McKesson. Comparable as a major pharma wholesaler with similar B2B distribution model, serving pharmacies and hospitals across European markets including Greece.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat3 records

Key risks4 records

Key highlights3 records

Customer concentration

Aenorasis social profiles

Digital presence

Aenorasis financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Aenorasis leadership team

Management profile

Number of profiles

Aenorasis funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Aenorasis M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aenorasis

What does Aenorasis do?

Aenorasis is a pharmaceutical distribution company based in Athens, Greece, founded in 1998. It specializes in distributing medical devices, therapeutic products, and diagnostic products to healthcare customers. The company operates with 51-100 employees and focuses on the supply of healthcare-related products.

When was Aenorasis founded?

Aenorasis was founded in 1998. It employs 1 to 10 people.

Where is Aenorasis based?

Aenorasis is headquartered in Athens, Greece, in the Europe region.

Who are Aenorasis's main competitors?

Help Pharmaceuticals is listed as a direct peer. Regional players are Uni-Pharma, Elpen Pharmaceutical, Genepharm and Lavipharm. Broad incumbents are Alliance Healthcare (Walgreens Boots Alliance), Phoenix Group and Celesio (McKesson Europe).

Does Aenorasis have an API?

No public API is recorded for Aenorasis.

What industry is Aenorasis in?

Aenorasis's product category is Pharmaceutical Distribution. Its primary akta.pro industry code is HLAIAJAC, OTC & Consumer Health Distributors. Its NAICS code is 42421 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales